{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:52:51Z","timestamp":1779202371547,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bezmialem Scientific Research Projects Unit","award":["20230908"],"award-info":[{"award-number":["20230908"]}]},{"name":"Bezmialem Scientific Research Projects Unit","award":["20230908"],"award-info":[{"award-number":["20230908"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11448-2","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:48:40Z","timestamp":1753703320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical, histological, and immunohistochemical signatures of non-segmental vitiligo: A case-control analysis of Melan-A expression and CD8\u207a T-cell infiltration"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-0793","authenticated-orcid":false,"given":"Melin","family":"\u00d6zg\u00fcn Ge\u00e7er","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-4115","authenticated-orcid":false,"given":"G\u00f6khan","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"1","key":"11448_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","volume":"54","author":"K Boniface","year":"2018","unstructured":"Boniface, K., Seneschal, J., Picardo, M. & Ta\u00efeb, A. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy. Clin. Rev. Allergy Immunol. 54 (1), 52\u201367. https:\/\/doi.org\/10.1007\/s12016-017-8622-7 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"11448_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.526","author":"MB Haulrig","year":"2024","unstructured":"Haulrig, M. B. et al. The global epidemiology of vitiligo: A systematic review and meta-analysis of the incidence and prevalence. JEADV Clin. Pract. https:\/\/doi.org\/10.1002\/jvc2.526 (2024).","journal-title":"JEADV Clin. Pract."},{"issue":"1","key":"11448_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/bjd\/ljae282","volume":"192","author":"V Eleftheriadou","year":"2024","unstructured":"Eleftheriadou, V., Ahmed, A., Nesnas, J. & Nagra, R. The lifetime risk and impact of vitiligo across sociodemographic groups: a UK population-based cohort study. Br. J. Dermatol. 192 (1), 63\u201371. https:\/\/doi.org\/10.1093\/bjd\/ljae282 (2024).","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"11448_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12949","volume":"34","author":"J Seneschal","year":"2021","unstructured":"Seneschal, J., Boniface, K., D\u2019Arino, A. & Picardo, M. An update on vitiligo pathogenesis. Pigment Cell. Melanoma Res. 34 (2), 236\u2013243. https:\/\/doi.org\/10.1111\/pcmr.12949 (2021).","journal-title":"Pigment Cell. Melanoma Res."},{"key":"11448_CR5","doi-asserted-by":"publisher","first-page":"1072837","DOI":"10.3389\/fmed.2023.1072837","volume":"10","author":"Z Hu","year":"2023","unstructured":"Hu, Z. & Wang, T. Beyond skin white spots: vitiligo and associated comorbidities. Front. Med. 10, 1072837. https:\/\/doi.org\/10.3389\/fmed.2023.1072837 (2023).","journal-title":"Front. Med."},{"issue":"4","key":"11448_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3892\/etm.2021.9743","volume":"21","author":"SL Said-Fernandez","year":"2021","unstructured":"Said-Fernandez, S. L. et al. Novel immunological and genetic factors associated with vitiligo: A review. Experimental Therapeutic Med. 21 (4), 312. https:\/\/doi.org\/10.3892\/etm.2021.9743 (2021).","journal-title":"Experimental Therapeutic Med."},{"issue":"1","key":"11448_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13000-024-01520-2","volume":"19","author":"R Fan","year":"2024","unstructured":"Fan, R. & Gao, J. Establishment of a promising vitiligo mouse model for pathogenesis and treatment studies. Diagn. Pathol. 19 (1), 92. https:\/\/doi.org\/10.1186\/s13000-024-01520-2 (2024).","journal-title":"Diagn. Pathol."},{"key":"11448_CR8","doi-asserted-by":"publisher","first-page":"866703","DOI":"10.3389\/fimmu.2022.866703","volume":"13","author":"K Fukuda","year":"2022","unstructured":"Fukuda, K. Networks of CD8\u2009+\u2009T cell response activation in melanoma and vitiligo. Front. Immunol. 13, 866703. https:\/\/doi.org\/10.3389\/fimmu.2022.866703 (2022).","journal-title":"Front. Immunol."},{"issue":"6","key":"11448_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","volume":"116","author":"KS Lang","year":"2001","unstructured":"Lang, K. S. et al. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1. J. Invest. Dermatol. 116 (6), 891\u2013897. https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01363.x (2001).","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"11448_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","volume":"77","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues, M. et al. New discoveries in the pathogenesis and classification of vitiligo. J. Am. Acad. Dermatol. 77 (1), 1\u201313. https:\/\/doi.org\/10.1016\/j.jaad.2016.10.048 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"11448_CR11","doi-asserted-by":"publisher","unstructured":"Ezzedine, K. et al. \u2026 Vitiligo Global Issue Consensus Conference Panelists Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment cell & melanoma research, 25(3), E1\u2013E13. (2012). https:\/\/doi.org\/10.1111\/j.1755-148X.2012.00997.x","DOI":"10.1111\/j.1755-148X.2012.00997.x"},{"key":"11448_CR12","doi-asserted-by":"publisher","unstructured":"Seneschal, J. Clinical features of vitiligo and social impact on quality of life. Dermatology Practical Concept. 13 (4S2). https:\/\/doi.org\/10.5826\/dpc.1304S2a312S (2023). e2023312S.","DOI":"10.5826\/dpc.1304S2a312S"},{"issue":"3","key":"11448_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/ddg.14713","volume":"20","author":"M B\u00f6hm","year":"2022","unstructured":"B\u00f6hm, M. et al. S1 guideline: diagnosis and therapy of vitiligo. J. Der Deutschen Dermatologischen Gesellschaft = J. German Soc. Dermatology: JDDG. 20 (3), 365\u2013378. https:\/\/doi.org\/10.1111\/ddg.14713 (2022).","journal-title":"J. Der Deutschen Dermatologischen Gesellschaft = J. German Soc. Dermatology: JDDG"},{"issue":"2","key":"11448_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40257-022-00752-6","volume":"24","author":"KN Cunningham","year":"2023","unstructured":"Cunningham, K. N. & Rosmarin, D. Vitiligo treatments: review of current therapeutic modalities and JAK inhibitors. Am. J. Clin. Dermatol. 24 (2), 165\u2013186. https:\/\/doi.org\/10.1007\/s40257-022-00752-6 (2023).","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"11448_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000537810","volume":"240","author":"HJ Ju","year":"2024","unstructured":"Ju, H. J. & Bae, J. M. Bridging molecular mechanism and clinical practice in vitiligo treatment: an updated review. Dermatology (Basel Switzerland). 240 (3), 474\u2013486. https:\/\/doi.org\/10.1159\/000537810 (2024).","journal-title":"Dermatology (Basel Switzerland)"},{"issue":"4","key":"11448_CR16","doi-asserted-by":"publisher","first-page":"e2024239","DOI":"10.5826\/dpc.1404a239","volume":"14","author":"Y Wen","year":"2024","unstructured":"Wen, Y. et al. Knowledge structure and trends of vitiligo from 2002 to 2023: A bibliometric analysis. Dermatology Practical Concept. 14 (4), e2024239. https:\/\/doi.org\/10.5826\/dpc.1404a239 (2024).","journal-title":"Dermatology Practical Concept."},{"issue":"4","key":"11448_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4103\/ijd.ijd_673_23","volume":"69","author":"ZG Attal","year":"2024","unstructured":"Attal, Z. G., Gabay, S. I., Peles, G. & Horev, A. 100 Most-Cited articles in vitiligo: A bibliometric analysis. Indian J. Dermatology. 69 (4), 365. https:\/\/doi.org\/10.4103\/ijd.ijd_673_23 (2024).","journal-title":"Indian J. Dermatology"},{"issue":"12","key":"11448_CR18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/j.1468-3083.2012.04505.x","volume":"26","author":"KM Alghamdi","year":"2012","unstructured":"Alghamdi, K. M., Kumar, A., Ta\u00efeb, A. & Ezzedine, K. Assessment methods for the evaluation of vitiligo. J. Eur. Acad. Dermatology Venereology: JEADV. 26 (12), 1463\u20131471. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04505.x (2012).","journal-title":"J. Eur. Acad. Dermatology Venereology: JEADV"},{"issue":"4","key":"11448_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5826\/dpc.0404a18","volume":"4","author":"A Feily","year":"2014","unstructured":"Feily, A. Vitiligo extent tensity index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo. Dermatology Practical Concept. 4 (4), 81\u201384. https:\/\/doi.org\/10.5826\/dpc.0404a18 (2014).","journal-title":"Dermatology Practical Concept."},{"issue":"5","key":"11448_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jid.2022.10.021","volume":"143","author":"JH Lee","year":"2023","unstructured":"Lee, J. H. et al. Comorbidities in patients with vitiligo: A systematic review and Meta-Analysis. J. Invest. Dermatol. 143 (5), 777\u2013789e6. https:\/\/doi.org\/10.1016\/j.jid.2022.10.021 (2023).","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"11448_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/pcmr.12974","volume":"34","author":"V Thakur","year":"2021","unstructured":"Thakur, V., Bishnoi, A., Vinay, K., Kumaran, S. M. & Parsad, D. Vitiligo: translational research and effective therapeutic strategies. Pigment Cell. Melanoma Res. 34 (4), 814\u2013826. https:\/\/doi.org\/10.1111\/pcmr.12974 (2021).","journal-title":"Pigment Cell. Melanoma Res."},{"key":"11448_CR22","doi-asserted-by":"publisher","unstructured":"Yadav, A. K. Histopathology and Molecular Pathology of Vitiligo. InTechOpen. (2019). https:\/\/doi.org\/10.5772\/intechopen.84258","DOI":"10.5772\/intechopen.84258"},{"issue":"8","key":"11448_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/DAD.0000000000000539","volume":"38","author":"AK Yadav","year":"2016","unstructured":"Yadav, A. K., Singh, P. & Khunger, N. Clinicopathologic analysis of stable and unstable vitiligo: A study of 66 cases. Am. J. Dermatopathol. 38 (8), 608\u2013613. https:\/\/doi.org\/10.1097\/DAD.0000000000000539 (2016).","journal-title":"Am. J. Dermatopathol."},{"issue":"2","key":"11448_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/bjd\/ljae133","volume":"191","author":"V Eleftheriadou","year":"2024","unstructured":"Eleftheriadou, V. et al. Burden of disease and treatment patterns in patients with vitiligo: findings from a National longitudinal retrospective study in the UK. Br. J. Dermatol. 191 (2), 216\u2013224. https:\/\/doi.org\/10.1093\/bjd\/ljae133 (2024).","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"11448_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamadermatol.2021.4724","volume":"158","author":"K Gandhi","year":"2022","unstructured":"Gandhi, K. et al. Prevalence of vitiligo among adults in the united States. JAMA Dermatology. 158 (1), 43\u201350. https:\/\/doi.org\/10.1001\/jamadermatol.2021.4724 (2022).","journal-title":"JAMA Dermatology"},{"issue":"3","key":"11448_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","volume":"61","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Li, S. & Li, C. Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo. Clin. Rev. Allergy Immunol. 61 (3), 299\u2013323. https:\/\/doi.org\/10.1007\/s12016-021-08868-z (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"11448_CR27","unstructured":"Ahmed jan, N. & Masood, S. Vitiligo. In StatPearls. StatPearls Publishing (2023)."},{"issue":"9988","key":"11448_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine, K., Eleftheriadou, V., Whitton, M., van Geel, N. & London Vitiligo. Lancet (England), 386(9988), 74\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(14)60763-7 (2015).","journal-title":"England)"},{"issue":"2","key":"11448_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/0974-2077.112667","volume":"6","author":"K Sahni","year":"2013","unstructured":"Sahni, K. & Parsad, D. Stability in vitiligo: is there a perfect way to predict it? J. Cutan. Aesthetic Surg. 6 (2), 75\u201382. https:\/\/doi.org\/10.4103\/0974-2077.112667 (2013).","journal-title":"J. Cutan. Aesthetic Surg."},{"issue":"6","key":"11448_CR30","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1002\/ski2.460","volume":"4","author":"GN Pathak","year":"2024","unstructured":"Pathak, G. N., Tan, I. J., Bai, G., Dhillon, J. & Rao, B. K. Vitiligo: from mechanisms of disease to treatable pathways. Skin. Health Disease. 4 (6), e460. https:\/\/doi.org\/10.1002\/ski2.460 (2024).","journal-title":"Skin. Health Disease"},{"key":"11448_CR31","doi-asserted-by":"publisher","first-page":"1200963","DOI":"10.3389\/fmed.2023.1200963","volume":"10","author":"P Abdi","year":"2023","unstructured":"Abdi, P. et al. Non-invasive skin measurement methods and diagnostics for vitiligo: a systematic review. Front. Med. 10, 1200963. https:\/\/doi.org\/10.3389\/fmed.2023.1200963 (2023).","journal-title":"Front. Med."},{"key":"11448_CR32","doi-asserted-by":"publisher","first-page":"797026","DOI":"10.3389\/fcell.2021.797026","volume":"9","author":"WL Chang","year":"2021","unstructured":"Chang, W. L., Lee, W. R., Kuo, Y. C. & Huang, Y. H. Vitiligo: an autoimmune skin disease and its Immunomodulatory therapeutic intervention. Front. Cell. Dev. Biology. 9, 797026. https:\/\/doi.org\/10.3389\/fcell.2021.797026 (2021).","journal-title":"Front. Cell. Dev. Biology"},{"issue":"2","key":"11448_CR33","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/med.21754","volume":"41","author":"J Chen","year":"2021","unstructured":"Chen, J., Li, S. & Li, C. Mechanisms of melanocyte death in vitiligo. Med. Res. Rev. 41 (2), 1138\u20131166. https:\/\/doi.org\/10.1002\/med.21754 (2021).","journal-title":"Med. Res. Rev."},{"issue":"10","key":"11448_CR34","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1468-3083.2010.03605.x","volume":"24","author":"BN Akay","year":"2010","unstructured":"Akay, B. N., Bozkir, M., Anadolu, Y. & Gullu, S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J. Eur. Acad. Dermatology Venereology: JEADV. 24 (10), 1144\u20131150. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03605.x (2010).","journal-title":"J. Eur. Acad. Dermatology Venereology: JEADV"},{"issue":"10","key":"11448_CR35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/ijd.14055","volume":"57","author":"AM Dahir","year":"2018","unstructured":"Dahir, A. M. & Thomsen, S. F. Comorbidities in vitiligo: comprehensive review. Int. J. Dermatol. 57 (10), 1157\u20131164. https:\/\/doi.org\/10.1111\/ijd.14055 (2018).","journal-title":"Int. J. Dermatol."},{"issue":"12","key":"11448_CR36","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/jpm12122048","volume":"12","author":"AM Chivu","year":"2022","unstructured":"Chivu, A. M. et al. Vitiligo-Thyroid disease association: when, in whom, and why should it be suspected?? A systematic review. J. Personalized Med. 12 (12), 2048. https:\/\/doi.org\/10.3390\/jpm12122048 (2022).","journal-title":"J. Personalized Med."},{"key":"11448_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fendo.2017.00290","volume":"8","author":"E Baldini","year":"2017","unstructured":"Baldini, E. et al. Vitiligo and autoimmune thyroid disorders. Front. Endocrinol. 8, 290. https:\/\/doi.org\/10.3389\/fendo.2017.00290 (2017).","journal-title":"Front. Endocrinol."},{"issue":"2","key":"11448_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jid.2020.06.004","volume":"141","author":"RA Spritz","year":"2021","unstructured":"Spritz, R. A. & Santorico, S. A. The genetic basis of vitiligo. J. Invest. Dermatol. 141 (2), 265\u2013273. https:\/\/doi.org\/10.1016\/j.jid.2020.06.004 (2021).","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"11448_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","volume":"60","author":"T Narita","year":"2011","unstructured":"Narita, T. et al. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergology International: Official J. Japanese Soc. Allergology. 60 (4), 505\u2013508. https:\/\/doi.org\/10.2332\/allergolint.11-OA-0303 (2011).","journal-title":"Allergology International: Official J. Japanese Soc. Allergology"},{"issue":"1","key":"11448_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15570\/actaapa.2016.2","volume":"25","author":"A Kubanov","year":"2016","unstructured":"Kubanov, A., Proshutinskaia, D., Volnukhin, V., Katunina, O. & Abramova, T. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker. Acta Dermatovenerologica Alpina Pannonica Et Adriatica. 25 (1), 5\u20139. https:\/\/doi.org\/10.15570\/actaapa.2016.2 (2016).","journal-title":"Acta Dermatovenerologica Alpina Pannonica Et Adriatica"},{"key":"11448_CR41","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.12688\/f1000research.125285.1","volume":"11","author":"B Setyanto","year":"2022","unstructured":"Setyanto, B., Kalim, H., Poeranto, S. & Widasmara, D. Melan-A expression related to apoptosis of melanocytes in segmental and non-segmental vitiligo. F1000Research 11, 1211. https:\/\/doi.org\/10.12688\/f1000research.125285.1 (2022). Version 1; peer review: 1 approved, 1 approved with reservations.","journal-title":"F1000Research"},{"issue":"4","key":"11448_CR42","doi-asserted-by":"publisher","first-page":"921","DOI":"10.12816\/0034754","volume":"45","author":"MA El Kholy","year":"2016","unstructured":"El Kholy, M. A. Immunohistochemical expression of melan A and its relation to expression of CXCR3 in vitiligo lesions. Al-Azhar Med. J. 45 (4), 921\u2013930. https:\/\/doi.org\/10.12816\/0034754 (2016).","journal-title":"Al-Azhar Med. J."},{"issue":"1","key":"11448_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.20473\/bikk.V32.1.2020.17-2","volume":"32","author":"TIN Vaniary","year":"2020","unstructured":"Vaniary, T. I. N., Listiawan, M. Y. & Murtiastutik, D. Expression of Melan-A in depigmented skin of vitiligo patients. Berkala Ilmu Kesehatan Kulit Dan Kelamin \u2013. Periodical Dermatology Venereol. 32 (1), 17\u201320. https:\/\/doi.org\/10.20473\/bikk.V32.1.2020.17-2 (2020).","journal-title":"Periodical Dermatology Venereol."},{"issue":"4","key":"11448_CR44","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jid.2019.09.014","volume":"140","author":"T Hirai","year":"2020","unstructured":"Hirai, T., Whitley, S. K. & Kaplan, D. H. Migration and function of memory CD8\u2009+\u2009T cells in skin. J. Invest. Dermatol. 140 (4), 748\u2013755. https:\/\/doi.org\/10.1016\/j.jid.2019.09.014 (2020).","journal-title":"J. Invest. Dermatol."},{"key":"11448_CR45","doi-asserted-by":"publisher","unstructured":"Riding, R. L. & Harris, J. E. The Role of Memory CD8\u2009+\u2009T Cells in Vitiligo. Journal of immunology (Baltimore, Md.: 1950), 203(1), 11\u201319. (2019). https:\/\/doi.org\/10.4049\/jimmunol.1900027","DOI":"10.4049\/jimmunol.1900027"},{"issue":"11","key":"11448_CR46","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.jid.2023.03.1689","volume":"143","author":"MA Refat","year":"2023","unstructured":"Refat, M. A. et al. Lesional CD8\u2009+\u2009T-Cell number predicts surgical outcomes of Melanocyte-Keratinocyte transplantation surgery for vitiligo. J. Invest. Dermatol. 143 (11), 2275\u20132282e6. https:\/\/doi.org\/10.1016\/j.jid.2023.03.1689 (2023).","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"11448_CR47","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/labinvest.3780138","volume":"80","author":"R van den Wijngaard","year":"2000","unstructured":"van den Wijngaard, R. et al. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA\u2009+\u2009T cells at the perilesional site. Lab. Invest. 80 (8), 1299\u20131309. https:\/\/doi.org\/10.1038\/labinvest.3780138 (2000).","journal-title":"Lab. Invest."},{"issue":"1","key":"11448_CR48","doi-asserted-by":"publisher","first-page":"16580","DOI":"10.1038\/s41598-024-67494-9","volume":"14","author":"N Hla\u010da","year":"2024","unstructured":"Hla\u010da, N., Vi\u010di\u0107, M., Ka\u0161telan, M., Dekani\u0107, A. & Prpi\u0107-Massari, L. Analysis of Granulysin expression in vitiligo and halo-nevus. Sci. Rep. 14 (1), 16580. https:\/\/doi.org\/10.1038\/s41598-024-67494-9 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"11448_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1874372200802010105","volume":"2","author":"FMNP Aslanian","year":"2008","unstructured":"Aslanian, F. M. N. P. et al. Immunohistochemical findings in active vitiligo including depigmenting lesions and non-lesional skin. Open. Dermatology J. 2 (1), 105\u2013110. https:\/\/doi.org\/10.2174\/1874372200802010105 (2008).","journal-title":"Open. Dermatology J."},{"issue":"1","key":"11448_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/jewd.jewd_42_21","volume":"19","author":"TS Anbar","year":"2022","unstructured":"Anbar, T. S. et al. Subjective versus objective recognition of facial vitiligo lesions: detection of subclinical lesions by wood\u2019s light. J. Egypt. Women\u2019s Dermatol. Soc. 19 (1), 7\u201313. https:\/\/doi.org\/10.4103\/jewd.jewd_42_21 (2022).","journal-title":"J. Egypt. Women\u2019s Dermatol. Soc."},{"issue":"1","key":"11448_CR51","doi-asserted-by":"publisher","first-page":"e20154126","DOI":"10.1542\/peds.2015-4126","volume":"138","author":"K Ezzedine","year":"2016","unstructured":"Ezzedine, K. & Silverberg, N. A practical approach to the diagnosis and treatment of vitiligo in children. Pediatrics 138 (1), e20154126. https:\/\/doi.org\/10.1542\/peds.2015-4126 (2016).","journal-title":"Pediatrics"},{"issue":"3","key":"11448_CR52","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21608\/zumj.2019.7447.1030","volume":"25","author":"HD Gamil","year":"2019","unstructured":"Gamil, H. D., Assaf, M. I., Khater, M. H. & Fawzy, M. M. Histopathological findings in lesional and perilesional skin of vitiligo patients before and after narrow band ultraviolet B phototherapy. Zagazig Univ. Med. J. 25 (3), 326\u2013334. https:\/\/doi.org\/10.21608\/zumj.2019.7447.1030 (2019).","journal-title":"Zagazig Univ. Med. J."},{"key":"11448_CR53","doi-asserted-by":"crossref","unstructured":"Eltayesh, N. A. A. E. et al. Evaluation of CD4\/CD8 ratio in vitiligo patients and its correlation to activity and severity of the disease. The Egyptian Journal of Hospital Medicine, 98(1), 745\u2013754. https:\/\/doi.org\/10.21608\/EJHM.2025.411577van den,,& (2009). Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. The Journal of investigative dermatology, 129(9), 2220\u20132232. https:\/\/doi.org\/10.1038\/jid.2009.32 (2025).","DOI":"10.21608\/ejhm.2025.411577"},{"issue":"1","key":"11448_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.25259\/IJDVL_793_2023","volume":"91","author":"S Aulakh","year":"2025","unstructured":"Aulakh, S. et al. Differential expression of serum CXCL9 and CXCL10 levels in vitiligo patients and their correlation with disease severity and stability: A cross-sectional study. Indian J. Dermatol. Venereol. Leprol. 91 (1), 9\u201315. https:\/\/doi.org\/10.25259\/IJDVL_793_2023 (2025).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"4","key":"11448_CR55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/exd.12103","volume":"22","author":"NC Laddha","year":"2013","unstructured":"Laddha, N. C. et al. Vitiligo: interplay between oxidative stress and immune system. Exp. Dermatol. 22 (4), 245\u2013250. https:\/\/doi.org\/10.1111\/exd.12103 (2013).","journal-title":"Exp. Dermatol."},{"issue":"3","key":"11448_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1346-8138.15743","volume":"48","author":"C Bergqvist","year":"2021","unstructured":"Bergqvist, C. & Ezzedine, K. Vitiligo: A focus on pathogenesis and its therapeutic implications. J. Dermatol. 48 (3), 252\u2013270. https:\/\/doi.org\/10.1111\/1346-8138.15743 (2021).","journal-title":"J. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11448-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11448-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11448-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:03:17Z","timestamp":1754092997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11448-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11448"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11448-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27425"}}